173 related articles for article (PubMed ID: 19094976)
21. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
[TBL] [Abstract][Full Text] [Related]
22. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Anderson KS; Ramachandran N; Wong J; Raphael JV; Hainsworth E; Demirkan G; Cramer D; Aronzon D; Hodi FS; Harris L; Logvinenko T; LaBaer J
J Proteome Res; 2008 Apr; 7(4):1490-9. PubMed ID: 18311903
[TBL] [Abstract][Full Text] [Related]
23. Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Ingvarsson J; Wingren C; Carlsson A; Ellmark P; Wahren B; Engström G; Harmenberg U; Krogh M; Peterson C; Borrebaeck CA
Proteomics; 2008 Jun; 8(11):2211-9. PubMed ID: 18528842
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of sandwich ELISA microarrays with minimal assay interference.
Gonzalez RM; Seurynck-Servoss SL; Crowley SA; Brown M; Omenn GS; Hayes DF; Zangar RC
J Proteome Res; 2008 Jun; 7(6):2406-14. PubMed ID: 18422355
[TBL] [Abstract][Full Text] [Related]
25. Using protein microarrays to study cancer.
Sreekumar A; Chinnaiyan AM
Biotechniques; 2002 Dec; Suppl():46-53. PubMed ID: 12514929
[TBL] [Abstract][Full Text] [Related]
26. Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays.
Murphy MA; O'Connell DJ; O'Kane SL; O'Brien JK; O'Toole S; Martin C; Sheils O; O'Leary JJ; Cahill DJ
J Proteomics; 2012 Aug; 75(15):4668-75. PubMed ID: 22415278
[TBL] [Abstract][Full Text] [Related]
27. Screening for genes associated with ovarian cancer prognosis.
Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and analytical applications of protein microarrays.
Dufva M; Christensen CB
Expert Rev Proteomics; 2005 Jan; 2(1):41-8. PubMed ID: 15966851
[TBL] [Abstract][Full Text] [Related]
29. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
30. Native antigen fractionation protein microarrays for biomarker discovery.
Caiazzo RJ; O'Rourke DJ; Barder TJ; Nelson BP; Liu BC
Methods Mol Biol; 2011; 723():129-48. PubMed ID: 21370063
[TBL] [Abstract][Full Text] [Related]
31. A concentration-dependent analysis method for high density protein microarrays.
Marina O; Biernacki MA; Brusic V; Wu CJ
J Proteome Res; 2008 May; 7(5):2059-68. PubMed ID: 18393456
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
33. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays.
Gupta S; Manubhai KP; Mukherjee S; Srivastava S
Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893
[TBL] [Abstract][Full Text] [Related]
34. Development of an individual-specific autoantibody (ISA) protein microarray.
Lebrun SJ; Suquilanda E; Petchpud WN
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):85-8. PubMed ID: 15151497
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel autoantibodies in ascites of relapsed paclitaxel-resistant gastric cancer with peritoneal metastasis using immunome protein microarrays and proteomics.
Yang Z; Yan C; Liu W; Xu W; Li C; Yan M; Liu B; Zhu Z
Cancer Biomark; 2021; 31(4):329-338. PubMed ID: 33896831
[TBL] [Abstract][Full Text] [Related]
36. High throughput proteomic strategies for identifying tumour-associated antigens.
Gunawardana CG; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):110-9. PubMed ID: 17306453
[TBL] [Abstract][Full Text] [Related]
37. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens.
Salama O; Herrmann S; Tziknovsky A; Piura B; Meirovich M; Trakht I; Reed B; Lobel LI; Marks RS
Biosens Bioelectron; 2007 Feb; 22(7):1508-16. PubMed ID: 16904309
[TBL] [Abstract][Full Text] [Related]
38. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.
Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E
Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250
[TBL] [Abstract][Full Text] [Related]
39. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody microarrays for biomarker discovery.
Caiazzo RJ; Tassinari OW; Ehrlich JR; Liu BC
Expert Rev Proteomics; 2007 Apr; 4(2):261-72. PubMed ID: 17425461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
